Generic Drugs
Affordable Treatment for Pulmonary Fibrosis
On October 14, 2020, Glenmark Pharma revealed that its launch NINDANIB, a generic version of Nintedanib, was effective to treat cases of pulmonary fibrosis. The drug has been cleared by Indian drug regulatory authorities. Glenmark Pharmaceuticals Glenmark Pharma has its generic drug markets across South America, the EU, U.S., and India. It has been a […]
Global Generic Drugs Market – Industry Analysis and Forecast (2018-2026)
Global Generic Drugs Market was valued at US$ 273 Bn in 2017, and is expected to reach US$ 630 Bn by 2026, at a CAGR of 11 % during forecast period. Generic drugs are manufactured and marketed after the expiry date of the patent or other exclusive rights.Generic drugs are bioequivalent to branded drugs in […]
Global Generic Drugs Market Industry Analysis and Forecast (2018-2026)
Global Generic Drugs Market was valued at US$ 273 Bn in 2017, and is expected to reach US$ 630 Bn by 2026, at a CAGR of 11 % during forecast period. Generic drugs are manufactured and marketed after the expiry date of the patent or other exclusive rights.Generic drugs are bioequivalent to branded drugs in […]